These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32990576)

  • 1. Aquapheresis: An Institutional Experience.
    Khine SK; Lam E; Dholakia K; Scheinerman SJ; DeVita M
    Heart Surg Forum; 2020 Sep; 23(5):E632-E635. PubMed ID: 32990576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aquapheresis (AQ) in Tandem with Extracorporeal Membrane Oxygenation (ECMO) in Pediatric Patients.
    Constantinescu AR; Adler JL; Watkins E; Negroni-Balasquide XL; Laufenberg D; Scholl FG; Lavandosky GJ
    J Extra Corpor Technol; 2019 Sep; 51(3):163-168. PubMed ID: 31548739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment identification of 90-day readmission among heart failure patients receiving aquapheresis treatment.
    Alkhatib D; Karabayir I; Pour-Ghaz I; Khan S; Hart L; Cease M; Khouzam RN; Jefferies JL; Akbilgic O
    Curr Probl Cardiol; 2024 Feb; 49(2):102207. PubMed ID: 37967805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of aquapheresis among hospitalized patients with end-stage liver disease: A case series and literature review.
    Crismale JF; Kim T; Schiano TD
    Clin Transplant; 2024 Jan; 38(1):e15221. PubMed ID: 38109221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using aquapheresis with continuous hematocrit monitoring to guide ultrafiltration.
    Starr MC; Voivodas M; Hains DS
    Pediatr Nephrol; 2024 Feb; 39(2):597-601. PubMed ID: 37661234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrafiltration for the treatment of diuretic-resistant, recurrent, acute decompensated heart failure: experience in a single center.
    De Maria E; Pignatti F; Patrizi G; Benenati PM; Ricci S; Cappelli S
    J Cardiovasc Med (Hagerstown); 2010 Aug; 11(8):599-604. PubMed ID: 20442667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrafiltration for management of fluid overload in patients with heart failure.
    Gologorsky RC; Roy S
    Artif Organs; 2020 Feb; 44(2):129-139. PubMed ID: 31361904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrafiltration in decompensated heart failure.
    Jaski BE; Miller D
    Curr Heart Fail Rep; 2005 Sep; 2(3):148-54. PubMed ID: 16138951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aquapheresis Versus Intravenous Diuretics and Hospitalizations for Heart Failure.
    Costanzo MR; Negoianu D; Jaski BE; Bart BA; Heywood JT; Anand IS; Smelser JM; Kaneshige AM; Chomsky DB; Adler ED; Haas GJ; Watts JA; Nabut JL; Schollmeyer MP; Fonarow GC
    JACC Heart Fail; 2016 Feb; 4(2):95-105. PubMed ID: 26519995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale and design of the Aquapheresis Versus Intravenous Diuretics and Hospitalization for Heart Failure (AVOID-HF) trial.
    Costanzo MR; Negoianu D; Fonarow GC; Jaski BE; Bart BA; Heywood JT; Nabut JL; Schollmeyer MP
    Am Heart J; 2015 Sep; 170(3):471-82. PubMed ID: 26385030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporating aquapheresis into the hospital setting: a practical approach.
    Peterangelo M
    Prog Cardiovasc Nurs; 2008; 23(4):168-72. PubMed ID: 19067980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indications for ultrafiltration in the cardiac surgical patient.
    Magilligan DJ
    J Thorac Cardiovasc Surg; 1985 Feb; 89(2):183-9. PubMed ID: 3968903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracorporeal fluid removal in heart failure patients.
    Costanzo MR; Ronco C
    Contrib Nephrol; 2010; 165():236-243. PubMed ID: 20427974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Non-pharmacological therapy of decompensated heart failure: the extracorporeal ultrafiltration].
    Tovena DM; Pedrinazzi C; Ogliari V; De Petri G; Mileti M; Inama G
    G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):118S-122S. PubMed ID: 19195319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracorporeal ultrafiltration for acute heart failure: patient selection and perspectives.
    Milazzo V; Cosentino N; Marenzi G
    Vasc Health Risk Manag; 2017; 13():449-456. PubMed ID: 29270016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with high-dose diuretics should get ultrafiltration in the management of decompensated heart failure: a meta-analysis.
    Shi X; Bao J; Zhang H; Wang H; Li L; Zhang Y
    Heart Fail Rev; 2019 Nov; 24(6):927-940. PubMed ID: 31209772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Miniaturized System for Ultrafiltration: Rationale and Design of a Single-Center, Crossover, Randomized, Open-Label, Pilot Study Protocol.
    Reis T; Sgarabotto L; Brendolan A; Lorenzin A; Corradi V; Marchionna N; Zanella M; Ronco C
    Cardiorenal Med; 2023; 13(1):176-183. PubMed ID: 37231837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of volume-overloaded cardiovascular patients treated with ultrafiltration.
    Jaski BE; Romeo A; Ortiz B; Hoagland PM; Stone M; Glaser D; Thomas L; Walsh C; Smith SC
    J Card Fail; 2008 Aug; 14(6):515-20. PubMed ID: 18672200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracorporeal fluid removal in heart failure patients.
    Costanzo MR; Agostoni P; Marenzi G
    Contrib Nephrol; 2010; 164():173-198. PubMed ID: 20428003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technical aspects of extracorporeal ultrafiltration: mechanisms, monitoring and dedicated technology.
    Nalesso F; Garzotto F; Ronco C
    Contrib Nephrol; 2010; 164():199-208. PubMed ID: 20428004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.